Document is current
Any future updates will be listed below
-
Authors
Zamò, Alberto
Gerhard-Hartmann, Elena
Ott, German
Anagnostopoulos, Ioannis
Scott, David W.
Rosenwald, Andreas
Rauert-Wunderlich, Hilka https://orcid.org/0000-0002-5535-2412
-
Funding
Funding for this research was provided by:
NanoString Technologies
Julius-Maximilians-Universität Würzburg
- License Information
-
More Information
Article History
Received: 11 June 2022
Revised: 7 September 2022
Accepted: 26 September 2022
First Online: 11 October 2022
Declarations
:
: This research used human case samples which were part of the biobank at the Institute of Pathology of the University of Würzburg, Germany, and samples were used according to the ethical guidelines of the Medical Faculty of the University of Würzburg.
: Andreas Rosenwald, David W.Scott and German Ott are named inventors on two patents filed by the National Cancer Institute: “Methods for selecting and treating lymphoma types” licensed to NanoString Technologies and “Evaluation of mantle cell lymphoma and methods related thereof.” Regarding this publication, all other authors have no competing interests to disclose.
